[Analogs of prostaglandin-related substances and inhibitors of their synthesis and metabolism. Clinical application: cardiovascular diseases]

Nihon Rinsho. 1985 Mar;43(3):578-82.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Angina Pectoris / drug therapy*
  • Aspirin / therapeutic use
  • Coronary Disease / blood
  • Epoprostenol / administration & dosage
  • Epoprostenol / blood
  • Epoprostenol / therapeutic use*
  • Humans
  • Hypertension / blood
  • Methacrylates / therapeutic use
  • Myocardial Infarction / drug therapy*
  • Oxidoreductases / antagonists & inhibitors*
  • Platelet Aggregation
  • Thromboxane-A Synthase / antagonists & inhibitors*
  • Thromboxanes / blood
  • Urokinase-Type Plasminogen Activator / administration & dosage

Substances

  • Methacrylates
  • Thromboxanes
  • 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid
  • Epoprostenol
  • Oxidoreductases
  • Urokinase-Type Plasminogen Activator
  • Thromboxane-A Synthase
  • ozagrel
  • Aspirin